NDC 50090-6348-01 - Valsartan
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-6348
- Requested NDC
- 50090-6348-01
- Package NDCs from labels
- 50090-6348-0, 50090-6348-1, 50090-6348-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2023-10-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Valsartan - A-S Medication Solutions | A-S Medication Solutions | 2023-10-03 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-6348-0 | Valsartan | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 3 | |
| 50090-6348-1 | Valsartan | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-6348 | VALSARTAN (VALSARTAN) TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] | 3 | Current NDC, 2 package rows | 20231004_688b5c82-2eba-445c-869e-60609f5db86a.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-6348-0 | EA - Each | 50090-6348 | 3fdd390d-97da-453f-bac1-ed4f21cf6fa1 | 1 | 2023-03-13 |
| 50090-6348-1 | EA - Each | 50090-6348 | c7d673e6-6a96-47f0-b5c5-eb591005bdd6 | 1 | 2023-03-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Anubis Barcelona Protective Line | ETHYLHEXYL METHOXYCINNAMATE, BUTYL METHOXYDIBENZOYLMETHANE, ETHYLHEXYL SALICYLATE, OCTOCRYLENE | ANUBIS COSMETICS SL | ec83846f-11c0-8f59-e053-2995a90ab9d2 | 2023-09-01 | Warnings | 15FIX9V2JP |
| Anubis Barcelona Spa Line | ORYZA SATIVA (RICE) STARCH, PERLITE, PALMITIC ACID | ANUBIS COSMETICS SL | eb01a962-ab38-18ec-e053-2995a90acdeb | 2023-09-01 | Warnings | 15FIX9V2JP |
| Mannitol | MANNITOL | B. Braun Medical Inc. | d12cc802-b538-4065-a264-f474ff3b3043 | 2023-08-15 | Warnings, Adverse reactions | 3OWL53L36A |
| Valsartan | VALSARTAN | SQUARE PHARMACEUTICALS LIMITED | 5ee97546-2a7c-40fa-9e05-b7993a72dfbf | 2023-07-02 | Boxed warning, Warnings, Adverse reactions | 349200 349199 349201 349483 80M03YXJ7I |
| Sheer Tint Mineral Sunscreen Broad Spectrum SPF 50 - Light/Medium Shade | SPF 50 SUNSCREEN BROAD SPECTRUM - LIGHT/MEDIUM SHADE | Autumn Harp | fd6807e1-c8c0-b361-e053-6294a90aea0c | 2023-06-05 | Warnings | 15FIX9V2JP |
| Thinksport Mineral SPF 50 | ZINC OXIDE AND TITANIUM DIOXIDE | thinkOperations,LLC | 77b63c0b-353b-4f5f-95c7-6f7eeab81471 | 2023-05-30 | Warnings | 15FIX9V2JP |
| Think Kids Mineral SPF 50 | ZINC OXIDE AND TITANIUM DIOXIDE | thinkOperations,LLC | 25c59820-a08d-4abe-87ae-a787ac8b2ac2 | 2023-05-30 | Warnings | 15FIX9V2JP |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 1b72ecfd-a08d-48c5-a853-d3bc9ff882f1 | 2023-05-09 | Boxed warning, Warnings, Adverse reactions | 80M03YXJ7I |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Amneal Pharmaceuticals of New York LLC | d5a1db33-3046-407c-a557-6b41642164a9 | 2023-05-08 | Boxed warning, Warnings, Adverse reactions | 80M03YXJ7I |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Mylan Pharmaceuticals Inc. | 3ba1f9f9-0037-4522-8605-e27dc8552b5b | 2023-04-27 | Boxed warning, Warnings, Adverse reactions | 80M03YXJ7I |
| Ferrum Oxydatum | FERRUM OXYDATUM | Hahnemann Laboratories, INC. | f8b52d3f-3fe2-a850-e053-6394a90a5d9f | 2023-04-06 | 1K09F3G675 | |
| Mannitol | MANNITOL | Fresenius Kabi USA, LLC | c395e13d-6ea1-4104-8b37-669cfb982f04 | 2023-03-16 | Warnings, Adverse reactions | 3OWL53L36A |
| Mineral Sunscreen SPF 50 | ZINC OXIDE TITANIUM DIOXIDE | Topiderm, Inc. | 3a637542-0f79-47ae-815d-84d0036c737a | 2023-02-13 | Warnings | 15FIX9V2JP |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | ef100fa1-dd63-4287-8543-480a82ace168 | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | 80M03YXJ7I |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | f1ef2a2c-7b8d-4127-8f47-29e430fba70b | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | 80M03YXJ7I |
| valsartan | VALSARTAN | A-S Medication Solutions | 80987771-ccb4-4a9f-a395-0af4c2621e0a | 2023-02-04 | Boxed warning, Warnings, Adverse reactions | 349200 80M03YXJ7I |
| valsartan | VALSARTAN | A-S Medication Solutions | e352db8b-0485-492a-8734-0a415566d764 | 2023-02-04 | Boxed warning, Warnings, Adverse reactions | 349201 80M03YXJ7I |
| valsartan | VALSARTAN | A-S Medication Solutions | 9f5a400f-9cfc-4d25-a677-73cbb14375e2 | 2023-02-04 | Boxed warning, Warnings, Adverse reactions | 349199 80M03YXJ7I |
| Valsartan | VALSARTAN | A-S Medication Solutions | 506ab3dd-c5eb-4755-ad10-bc116f4443c7 | 2023-01-31 | Boxed warning, Warnings, Adverse reactions | ANDA203311 349199 80M03YXJ7I |
| Amlodipine and Valsartan | AMLODIPINE AND VALSARTAN | Alembic Pharmaceuticals Limited | a9c442dc-749e-4de0-bca3-1044eb78da72 | 2023-01-27 | Boxed warning, Warnings, Adverse reactions | 80M03YXJ7I |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.